The global optical coherence tomography market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2033, exhibiting a growth rate (CAGR) of 11.59% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.1 Billion |
Market Forecast in 2033
|
USD 5.8 Billion |
Market Growth Rate 2025-2033 | 11.59% |
Optical coherence tomography (OCT) refers to a non-invasive imaging technique used to obtain high-resolution cross-sectional images of the retina. Tabletop and handheld are some of the commonly available types of OCT devices. They consist of an interferometer and short-pulse lasers with low coherence and a broad bandwidth light source. OCT is widely used in various healthcare domains, such as ophthalmology, oncology, cardiovascular, and dermatology. It is also used to detect the retinal thickness and aids in the early detection and diagnosis of retinal diseases and conditions. It also provides precise imaging of neointimal stent strut coverage in follow-up exams and assists in the easier evaluation of stent strut apposition against the vessel wall.
The increasing incidences of retinal and choroidal disorders and visual impairments across the globe are creating a positive outlook for the market. Optical coherence tomography is widely used by an ophthalmologist for screening and diagnosing retinal-related disorders, including tear and detachment, diabetic retinopathy, macular hole, and retinitis pigmentosa. Apart from this, various product innovations, such as the introduction of higher-performing devices that assist in enhancing accuracy and improving the overall quality of eye care, are providing an impetus to the market growth. Additionally, the increasing geriatric population and rising instances of cancer are also favoring the market growth. Optical coherence tomography aids in early cancer detection and provides information on nuclear-to-cytoplasmic ratio, nuclear size and shape, and the organization and structure of glands. Other factors, including the increasing demand for early diagnosis methods, widespread product utilization in drug delivery, and significant improvements in healthcare technologies, are anticipated to drive the market further toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optical coherence tomography market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, technology and application.
Breakup by Type:
Breakup by Technology:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Technology, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global optical coherence tomography market was valued at USD 2.1 Billion in 2024.
We expect the global optical coherence tomography market to exhibit a CAGR of 11.59% during 2025-2033.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective detection and diagnosis of retinal diseases to reduce the risk of the coronavirus infection upon medical equipment, thereby negatively impacting the global market for optical coherence tomography technique.
The rising incidences of retinal and choroidal disorders, along with the introduction of advanced devices which assist to enhance accuracy as well as improve the overall quality of eye care, are primarily driving the global optical coherence tomography market.
Based on the type, the global optical coherence tomography market has been segmented into handheld OCT devices, tabletop OCT devices, and others. Currently, handheld OCT devices hold the majority of the total market share.
Based on the application, the global optical coherence tomography market can be divided into dermatology, ophthalmology, cardiovascular, oncology, and others. Among these, ophthalmology exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global optical coherence tomography market include Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc., and Topcon Corporation.